- Home
- PCVX vs FHN Comparison
PCVX vs FHN Comparison
Compare PCVX & FHN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- FHN
- Stock Information
- Founded
- PCVX 2013
- FHN 1864
- Country
- PCVX United States
- FHN United States
- Employees
- PCVX N/A
- FHN N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- FHN Major Banks
- Sector
- PCVX Health Care
- FHN Finance
- Exchange
- PCVX Nasdaq
- FHN Nasdaq
- Market Cap
- PCVX 4.4B
- FHN 10.7B
- IPO Year
- PCVX 2020
- FHN N/A
- Fundamental
- Price
- PCVX $35.28
- FHN $21.19
- Analyst Decision
- PCVX Strong Buy
- FHN Buy
- Analyst Count
- PCVX 10
- FHN 17
- Target Price
- PCVX $136.50
- FHN $23.09
- AVG Volume (30 Days)
- PCVX 1.5M
- FHN 6.1M
- Earning Date
- PCVX 08-05-2025
- FHN 07-16-2025
- Dividend Yield
- PCVX N/A
- FHN 2.81%
- EPS Growth
- PCVX N/A
- FHN N/A
- EPS
- PCVX N/A
- FHN 1.44
- Revenue
- PCVX N/A
- FHN $3,043,000,000.00
- Revenue This Year
- PCVX N/A
- FHN $11.18
- Revenue Next Year
- PCVX N/A
- FHN $3.73
- P/E Ratio
- PCVX N/A
- FHN $14.82
- Revenue Growth
- PCVX N/A
- FHN 3.43
- 52 Week Low
- PCVX $27.66
- FHN $14.34
- 52 Week High
- PCVX $121.06
- FHN $22.44
- Technical
- Relative Strength Index (RSI)
- PCVX 54.47
- FHN 53.48
- Support Level
- PCVX $31.79
- FHN $21.67
- Resistance Level
- PCVX $36.89
- FHN $22.22
- Average True Range (ATR)
- PCVX 1.55
- FHN 0.43
- MACD
- PCVX 0.37
- FHN -0.01
- Stochastic Oscillator
- PCVX 68.43
- FHN 48.76
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About FHN First Horizon Corporation
First Horizon Corp is the parent company of First Tennessee Bank, a prominent regional bank with about 200 branches around Tennessee. The company's reportable segments are: Commercial, Consumer & Wealth, Wholesale, and Corporate. The majority of its revenue is generated from Commercial, Consumer & Wealth. The Commercial, Consumer & Wealth segment offers financial products and services, including traditional lending and deposit taking, to commercial and consumer clients in the southern USA and other selected markets.